The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Innovations / Novel technologies

Boston Scientific Lotus valve

EuroIntervention 2012;8:Q70-Q74. DOI: 10.4244/EIJV8SQA12

1. MonashHEART, Southern Health, Monash Medical Centre, Clayton, Victoria, Australia; 2. Boston Scientific Corporation, Natick, MA, USA

As a result of recent randomised controlled trials and registry observations, transcatheter aortic valve replacement (TAVR) enjoys growing appeal for the treatment of patients at high or extreme risk from sur

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Direct Flow Medical valve